Think Hollywood is out of ideas? They’ve got nothing on the drug industry. Especially when it comes to fighting dementia.
Big Pharma has been recycling failed drugs more than Marvel recycles superhero plots. And they’ve just done it yet again.
The latest “new” attempt at an Alzheimer’s drug is based on the same old approach. You know, the one that’s already FAILED repeatedly.
Well, it probably doesn’t come as a shocker that it failed yet again.
So today, let’s go off-script and look where the drug industry refuses. Because while the pharmaceutical companies keep pushing the same old dementia drug failures, promising research shows where we might finally find some success.
And you may even be able to put this approach to work for you and your loved ones at risk for this disease.
Dementia drug is a dud… again
The newest treatment targets beta-amyloid. Those are the dangerous “brain plaques” closely linked to Alzheimer’s disease.
And if that sounds familiar, it’s because we’ve been down this road before… lots of times.
Since those plaques are so closely linked to dementia, the drug industry has assumed clearing them – or at least reducing them – is the key to stopping the disease. But so far, that’s NOT how it’s worked in reality.
And that’s not how it worked in the new study, which focused on a very specific set of patients. The research targeted folks with a very high genetic risk of developing dementia at earlier-than-expected ages. It’s a condition called early-onset Autosomal Dominant Alzheimer’s Disease.
The drug, crenezumab, did nothing.
Now, you might think it’s worth a shot in patients with “regular” Alzheimer’s. Except they already tried that – and it flopped there, too, at least twice.
As I said, we’ve been down this road before… and not just with this dementia drug. Other experimental meds have also flunked studies. Yet, at least one of them was approved anyway.
Even the conventional experts were alarmed by that decision. Because along with potentially NOT working (despite that approval), there are significant safety concerns over the drug.
But that doesn’t mean you’re powerless against dementia.
A better approach to reducing Alzheimer’s risks
We all know people who bought a lemon of a car and had to keep dumping cash into it. At some point, you’ve got to give up on the vehicle. Yet many people don’t, sinking good money into the lemon after bad.
The drug industry’s like that with dementia meds that target amyloid. They keep repurposing the duds, dumping more money and time into them long after they’ve flopped.
That won’t change now that they know there’s a chance the FDA will approve the meds anyway. But that won’t help you, either.
Fortunately, other science-backed options can help fight back against dementia – especially if you act as early as possible.
For example, research has backed a B complex (B6, B12, and folic acid) to slow brain shrink, another hallmark of decline and dementia. Other studies have found that the same supplement may also help with memory loss.
Some other promising natural options to support brain health include high-dose omega-3 fatty acids, curcumin, huperzine a, grape seed extract, ginkgo biloba, and green tea extract.
And don’t overlook the importance of good, quality sleep. When you’re sleeping, your brain activates its own natural detox process, clearing out amyloid plaques and other junk BEFORE it has a chance to cause any problems.
For more on how to protect your brain with better slumber, including the answer to the age-old question of how long your snooze sessions should last, check out my earlier report, “Dodge dementia with the SLEEP WINDOW method.”
Latest posts by Alice Jacob (see all)
- BEFORE you pop that weight-loss pill read THIS - August 15, 2022
- Shut down “zombie cells” to slow aging to a crawl - August 14, 2022
- Diabetic? THIS number is key [NOT daily blood sugar] - August 13, 2022